McKesson Corporation $MCK Shares Bought by Groupama Asset Managment

Groupama Asset Managment lifted its position in shares of McKesson Corporation (NYSE:MCK) by 28.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,596 shares of the company’s stock after purchasing an additional 807 shares during the quarter. Groupama Asset Managment’s holdings in McKesson were worth $2,778,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC increased its holdings in McKesson by 46.3% in the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after buying an additional 798 shares in the last quarter. Caxton Associates LLP purchased a new stake in shares of McKesson during the 1st quarter worth about $233,000. Sivia Capital Partners LLC grew its position in shares of McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after acquiring an additional 300 shares during the period. Avantax Advisory Services Inc. grew its position in shares of McKesson by 7.6% during the 2nd quarter. Avantax Advisory Services Inc. now owns 4,556 shares of the company’s stock valued at $3,339,000 after acquiring an additional 320 shares during the period. Finally, Wealthspire Advisors LLC increased its stake in shares of McKesson by 4.5% in the 2nd quarter. Wealthspire Advisors LLC now owns 1,310 shares of the company’s stock valued at $960,000 after purchasing an additional 56 shares in the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Maria Martinez sold 349 shares of the company’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director directly owned 301 shares of the company’s stock, valued at approximately $282,900.87. This represents a 53.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 3,868 shares of company stock valued at $3,743,820. Company insiders own 0.08% of the company’s stock.

McKesson Price Performance

Shares of NYSE:MCK opened at $898.82 on Friday. The business’s 50 day moving average price is $902.24 and its 200-day moving average price is $831.10. The firm has a market capitalization of $110.10 billion, a PE ratio of 25.85, a P/E/G ratio of 1.48 and a beta of 0.38. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, beating the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the company earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be given a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio is 9.43%.

Analyst Upgrades and Downgrades

MCK has been the subject of a number of analyst reports. Leerink Partners reaffirmed an “outperform” rating and issued a $1,085.00 price target on shares of McKesson in a report on Thursday, March 5th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. TD Cowen increased their target price on McKesson from $1,000.00 to $1,012.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Wall Street Zen lowered shares of McKesson from a “buy” rating to a “hold” rating in a report on Saturday, March 14th. Finally, Wells Fargo & Company lifted their target price on shares of McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, McKesson presently has a consensus rating of “Moderate Buy” and an average price target of $960.93.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.